spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  CATANIA 

 HSMN NewsFeed - 4 Apr 2019
DelMar Pharmaceuticals Welcomes Dr. John de Groot, Chairman, ad interim of the Department of Neuro-Oncology at MD Anderson Cancer Center, as founding member of the Company's Scientific Advisory Board
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 25 Jun 2018
DelMar Pharmaceuticals Appoints World-Renowned Molecular Biologist Dr. Napoleone Ferrara to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Feb 2017
Alimera Sciences Announces the Reimbursement of ILUVIEN(R) in Italy
Biopharmaceuticals Ophthalmology Reimbursement
 HSMN NewsFeed - 17 Oct 2012
Loma Vista Medical Receives FDA Clearance for its TRUE Dilatation(TM) Balloon Valvuloplasty Catheter
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 27 Apr 2012
BIOTRONIK Evia HF-T, World's First MRI-Approved CRT Pacemaker
Devices Cardiology
 HSMN NewsFeed - 18 Feb 2011
Largest Study of Medtronic CoreValve(R) System Confirms Positive Clinical Outcomes
Devices Interventional Cardiology
 HSMN NewsFeed - 10 Jun 2010
Boston Scientific Announces European Launch and First Implants of Platinum Chromium TAXUS(R) Element Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 6 Oct 2009
Scientific Paper Supports Micro-Bland Embolization Technique for Liver Cancer With Embozene(TM) Microspheres
Devices Oncology
 HSMN NewsFeed - 16 Sep 2009
New Micro-Bland Embolization Technique with Embozene(TM) Microspheres to Be Presented at the International Medical Conference in Lisbon, Portugal
Devices Oncology
 HSMN NewsFeed - 6 Apr 2009
First Patients Enrolled in the Access-Europe Study of The MitraClip(R) Therapy
Devices Interventional Cardiology
 HSMN NewsFeed - 1 Jan 2009
First U.S. Implants of Newly Approved Embozene(TM) Color-Advanced Microspheres Embolization Platform
Devices Interventional Oncology
 HSMN NewsFeed - 16 Dec 2008
CeloNova BioSciences Receives FDA Market Approval for Embozene(TM) Color-Advanced Microspheres Embolization Platform
Devices Interventional FDA
 HSMN NewsFeed - 21 Oct 2008
First Patients Treated in Italy With the Percutaneous MitraClip(R) System
Devices Interventional Cardiology
 HSMN NewsFeed - 13 Oct 2008
12-Month ATLANTA Trial Data Show Sustained Benefit of Catania(TM) Stent in Treatment of De Novo Coronary Lesions
Devices Interventional Cardiology
 HSMN NewsFeed - 7 Oct 2008
CeloNova BioSciences to Showcase the CE-Marked CATANIA(TM) Coronary Stent System Featuring NanoThin Polyzene(R)-F at TCT Debut
Devices Interventional Cardiology
 HSMN NewsFeed - 21 Jan 2008
Super-Thin Drug-Free Coating 'Hides' Stent as It Unblocks Heart Arteries
Devices Interventional Cardiology
 HSMN NewsFeed - 20 Jan 2008
CeloNova BioSciences Announces Positive Results from European Study of Embozene(TM) Microspheres for Treatment of Uterine Fibroids
Devices Interventional
 HSMN NewsFeed - 20 Jan 2008
CeloNova BioSciences Introduces a New Class of Coronary Stent: The CATANIA(TM) Coronary Stent System with NanoThin Polyzene(R)-F
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Oct 2007
Datascope Names Chief Operating Officer
Devices Cardiology Monitoring Personnel
 HSMN NewsFeed - 13 Sep 2007
Sorin Group: Celebrates 30 Years of Clinical Use of Its Heart Valves and Highlights Activities at EACTS 2007
Devices Cardiology
Return to NewsFeed  

 Additional items found! 3

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 3 additional stories matching:
CATANIA
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.